Madrigal Pharmaceuticals (MDGL) has had the highest return since November 11, 2025 by a large-cap US stock, returning 10.2%.
| ASSET | % RETURN |
|---|---|
Madrigal Pharmaceuticals (MDGL) | 10.2% |
Rivian Automotive (RIVN) | 10.01% |
Viatris (VTRS) | 9.49% |
Moderna (MRNA) | 5.85% |
BridgeBio Pharma (BBIO) | 5.48% |
FedEx (FDX) | 5.16% |
Joby Aviation (JOBY) | 5.14% |
AngloGold Ashanti (AU) | 4.85% |
Summit Therapeutics (SMMT) | 4.76% |
BeiGene (ONC) | 4.69% |
Coca-Cola Consolidated (COKE) | 4.66% |
Amgen (AMGN) | 4.65% |
Ionis Pharmaceuticals (IONS) | 4.52% |
Novo Nordisk A-S (NVO) | 4.42% |
Akamai Technologies (AKAM) | 4.2% |
Pfizer (PFE) | 4.16% |
Merck (MRK) | 4.12% |
Dollar General (DG) | 3.76% |
Align Technology (ALGN) | 3.71% |
Exelixis (EXEL) | 3.69% |
Rocket Companies (RKT) | 3.66% |
Biomarin Pharmaceutical (BMRN) | 3.64% |
TPG (TPG) | 3.62% |
Regeneron Pharmaceuticals (REGN) | 3.54% |
Genmab A-S (GMAB) | 3.48% |
Large-cap stocks are treated as having a market cap of $10B+.
